FATE position history
The shares of Fate Therapeutics (FATE) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 344,360 shares, $20M, 5.4% of portfolio
- 2021 Q4: 372,160 shares, $22M, 5.5% of portfolio, Add +8.1%
- 2022 Q1: 500,930 shares, $19M, 5.1% of portfolio, Add +34.6%
- 2022 Q2: 550,940 shares, $14M, 3.7% of portfolio, Add +10.0%
- 2022 Q3: 539,940 shares, $12M, 3.3% of portfolio, Reduce −2.0%
- 2022 Q4: 550,940 shares, $5.6M, 1.6% of portfolio, Add +2.0%
- 2023 Q1: not held, Exit
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: 550,000 shares, $540K, 0.13% of portfolio, New
- 2026 Q1: 550,000 shares, $660K, 0.15% of portfolio
- 2026 Q2: 525,000 shares, $1.4M, 0.27% of portfolio, Reduce −4.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|